Treatment of chronic hepatitis C: The new standard of care for the future; Focus On Fidaxomicin: New therapy for Clostridium difficile-associated diarrhea
Are PBMs Putting GLP-1 Drugs on Their Formularies?
October 11th 2024PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is uneven. What is needed is more data about whether these drugs can lower overall healthcare costs.
Read More